UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

On the adhesive JKR contact and rolling models for reduced particle stiffness discrete element simulations

Powder technology, 2017-09, Vol.319, p.472-482

2017

Volltextzugriff (PDF)

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

Annals of internal medicine, 2000-07, Vol.133 (1), p.35

2000

Volltextzugriff (PDF)

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up

JAMA : the journal of the American Medical Association, 1998-07, Vol.280 (1), p.35

1998

Volltextzugriff (PDF)

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

Journal of Virology, 1996-12, Vol.70 (12), p.8270-8276

1996

Volltextzugriff (PDF)

L-735,524: An Orally Bioavailable Human Immunodeficiency Virus Type 1 Protease Inhibitor

Proceedings of the National Academy of Sciences - PNAS, 1994-04, Vol.91 (9), p.4096-4100

1994

Volltextzugriff (PDF)

Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease Inhibitor Therapy

The Journal of infectious diseases, 2000-09, Vol.182 (3), p.758-765

2000

Volltextzugriff (PDF)

Resisting resistance: maximizing the durability of antiretroviral therapy

Annals of internal medicine, 1998-06, Vol.128 (11), p.951

Condra, J H

1998

Volltextzugriff (PDF)

Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors

Antimicrobial Agents and Chemotherapy, 1993-08, Vol.37 (8), p.1576-1579

1993

Volltextzugriff (PDF)

5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase

Journal of medicinal chemistry, 1993-04, Vol.36 (9), p.1291-1294

1993

Volltextzugriff (PDF)

Resistance to HIV protease inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 1998-07, Vol.4 (4), p.610-615

1998

Volltextzugriff (PDF)

Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors

The Journal of biological chemistry, 1992-09, Vol.267 (25), p.17526-17530

1992

Volltextzugriff (PDF)

Sequence-Specific Interaction of Tat Protein and Tat Peptides with the Transactivation-Responsive Sequence Element of Human Immunodeficiency Virus Type 1 in vitro

Proceedings of the National Academy of Sciences - PNAS, 1990-11, Vol.87 (22), p.8985-8989

1990

Volltextzugriff (PDF)

Evidence for the Direct Involvement of the Rhinovirus Canyon in Receptor Binding

Proceedings of the National Academy of Sciences - PNAS, 1988-08, Vol.85 (15), p.5449-5453

1988

Volltextzugriff (PDF)

POTENTIAL NEW THERAPIES FOR THE TREATMENT OF HIV-1 INFECTION

Annual review of medicine, 2002-01, Vol.53 (1), p.541-555

2002

Volltextzugriff (PDF)

Prevalence and predictive value of intermittent viremia with combination hiv therapy

JAMA : the journal of the American Medical Association, 2001-07, Vol.286 (2), p.171

2001

Volltextzugriff (PDF)

Factors Influencing the Emergence of Resistance to Indinavir: Role of Virologic, Immunologic, and Pharmacologic Variables

The Journal of infectious diseases, 1998-08, Vol.178 (2), p.360-367

1998

Volltextzugriff (PDF)

Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors

Antimicrobial Agents and Chemotherapy, 1992-07, Vol.36 (7), p.1441-1446

1992

Volltextzugriff (PDF)

Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reverse transcriptase inhibitors

Antimicrobial agents and chemotherapy, 1994, Vol.38 (6), p.1404-1407

1994

Volltextzugriff (PDF)

Treatment with Indinavir, Efavirenz, and Adefovir after Failure of Nelfinavir Therapy

The Journal of infectious diseases, 2003-04, Vol.187 (7), p.1157-1162

2003

Volltextzugriff (PDF)

Baseline Human Immunodeficiency Virus Type 1 Phenotype, Genotype, and RNA Response after Switching from Long-Term Hard-Capsule Saquinavir to Indinavir or Soft-Gel—Capsule Saquinavir in AIDS Clinical Trials Group Protocol 333

The Journal of infectious diseases, 2000-09, Vol.182 (3), p.733-743

2000

Volltextzugriff (PDF)

Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence

The Journal of biological chemistry, 1993-01, Vol.268 (1), p.276-281

1993

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 Protease Inhibitors: Evaluation of Resistance Engendered by Amino Acid Substitutions in the Enzyme's Substrate Binding Site

Biochemistry (Easton), 1994-03, Vol.33 (8), p.2004-2010

1994

Volltextzugriff (PDF)

A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors

Antimicrobial Agents and Chemotherapy, 1993-05, Vol.37 (5), p.947-949

1993

Volltextzugriff (PDF)

Assessment of patient satisfaction with a formulary switch from omeprazole to lansoprazole in gastroesophageal reflux disease maintenance therapy

The American journal of managed care, 1999-05, Vol.5 (5), p.631

1999

Volltextzugriff (PDF)

Expression of a recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein

Journal of Virology, 1983-02, Vol.45 (2), p.773-781

1983

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Englisch
(86)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(44)
Humans
(33)
Biological And Medical Sciences
(29)
Medical Sciences
(19)
Aids/hiv
(18)
Animals
(14)
Hiv
(13)
Male
(13)
Microbiology
(13)
Pharmacology. Drug Treatments
(13)
Virology
(13)
Hiv Infections - Drug Therapy
(12)
Human Immunodeficiency Virus 1
(12)
Drug Resistance, Microbial
(11)
Fundamental And Applied Biological Sciences. Psychology
(11)
Hiv-1 - Drug Effects
(11)
Hiv-1 - Genetics
(11)
Amino Acid Sequence
(10)
Antiviral Agents
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

On the adhesive JKR contact and rolling models for reduced particle stiffness discrete element simulations

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

L-735,524: An Orally Bioavailable Human Immunodeficiency Virus Type 1 Protease Inhibitor

Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease Inhibitor Therapy

Resisting resistance: maximizing the durability of antiretroviral therapy

Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors

5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase

Resistance to HIV protease inhibitors

Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors

Sequence-Specific Interaction of Tat Protein and Tat Peptides with the Transactivation-Responsive Sequence Element of Human Immunodeficiency Virus Type 1 in vitro

Evidence for the Direct Involvement of the Rhinovirus Canyon in Receptor Binding

POTENTIAL NEW THERAPIES FOR THE TREATMENT OF HIV-1 INFECTION

Prevalence and predictive value of intermittent viremia with combination hiv therapy

Factors Influencing the Emergence of Resistance to Indinavir: Role of Virologic, Immunologic, and Pharmacologic Variables

Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors

Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reverse transcriptase inhibitors

Treatment with Indinavir, Efavirenz, and Adefovir after Failure of Nelfinavir Therapy

Baseline Human Immunodeficiency Virus Type 1 Phenotype, Genotype, and RNA Response after Switching from Long-Term Hard-Capsule Saquinavir to Indinavir or Soft-Gel—Capsule Saquinavir in AIDS Clinical Trials Group Protocol 333

Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence

Human Immunodeficiency Virus Type 1 Protease Inhibitors: Evaluation of Resistance Engendered by Amino Acid Substitutions in the Enzyme's Substrate Binding Site

A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors

Assessment of patient satisfaction with a formulary switch from omeprazole to lansoprazole in gastroesophageal reflux disease maintenance therapy

Expression of a recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein

Aktive Filter

Suchergebnisse filtern